Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Clinical Trials in the EU / 2026-525977-38-00
Authorised, not yet recruiting Phase IV

The Swedish study of shortened antibiotic treatment after surgery for Pediatric Acute Perforated Appendicitis; a randomized controlled non-inferiority study (RCT) comparing 3 versus 5 days of postoperative antibiotics.

2026-525977-38-00 · tracked via the Priya Life Science EU tracker
Sponsor type
Hospital/Clinic/Other health care facility
Therapeutic area
Digestive System Diseases
Decision date
03/11/2026
Enrollment target
470
Sites
Sweden

Condition studied

Paediatric Acute Perforated Appendicitis - postoperative treatment

Investigational medicinal product(s)

Metronidazol EQL Pharma 400 mg filmdragerade tabletterPiperacillin/Tazobactam 2 g/0.25 g powder for solution for infusionSpektramox 80 mg/ml+12 mg/ml pulver till oral suspensionCefotaxim Navamedic 1 g pulver till injektions-/infusionsvätskalösning.Ciprofloxacin Fresenius Kabi2mg/ml infusionsvätskalösningDalacin 15 mg/ml granulat till oral lösning

Every trial of Clindamycin and Ciprofloxacin across our registers →

Eligibility

Age group
0-17 years
Sex
Female, Male

Primary endpoint

Postoperative infectious complications within 30 days after surgery for APA (Intraabdominal abscess, Wound infection, Other?)

Endpoint detail

Complications according to Clavien Madadi within 30 days of surgery., Reoperations or radiological interventions within 30 days and reasons for re-intervention (drainage of abscess, surgery for intestinal obstruction etc)., Readmissions within 30 days and reasons for that (infection, pain, other), Total length of stay in hospital after surgery for APA., Total number of adverse reactions to antibiotic treatment (allergic reaction or other) and differences between groups?, Number of participants in the study population with a need for prolonged antibiotics and distribution between treatment groups? This will be regarded as a composite endpoint., Total length of antibiotic treatment (per protocol) and number of individuals who have restarted antibiotic treatment within 30 days after surgery., Reason for prolonged antibiotic treatment in cases where there is prolonged antibiotic treatment?, Type and number of postoperative imaging studies, Type and number of surgical or radiological re-interventions., Time (days) to return to preschool/school/work (child/parent) in total and with 3 compared to 5 days of postoperative antibiotics?, Pre-operative risk factors such as: a, long duration of symptoms before surgery, b, age, c, gender, d, CRP>135 and e,low S-Na and correlation to postoperative complications?, Peri-operative risk factors such as f, time from arrival at emergency department to surgery (hours), g, time for surgery (hours), h, method of surgery, (laparoscopy/converted/open), i, appearance appendix at time of surgery and j, leakage of feces in abdomen correlated to postoperative complications after surgery for APA?, Post-operative risk factors such as: k, level of leucocytes and l, CRP at day 3 and correlation to postoperative complications after surgery for APA be identified?

Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2026-525977-38-00 on CTIS ↗ ← All trials in the EU